GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa

Go back to GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa
AGENUS (NASDAQ: AGEN) Delayed: 3.04 --0 (-0%)
Previous Close $3.04    52 Week High $7.49 
Open $3.04    52 Week Low $2.61 
Day High $3.04    P/E N/A 
Day Low $3.04    EPS $-1.10 
Volume 1,021       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.74 --0 (-0%)
Previous Close $50.74    52 Week High $45.58 
Open $50.74    52 Week Low $37.82 
Day High $50.74    P/E N/A 
Day Low $50.74    EPS $0.00 
Volume 11,637